Home/Filings/4/0001104659-20-023968
4//SEC Filing

Sofinnova HealthQuest Partners, L.P. 4

Accession 0001104659-20-023968

CIK 0001447362other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:22 PM ET

Size

8.7 KB

Accession

0001104659-20-023968

Insider Transaction Report

Form 4
Period: 2020-02-19
Transactions
  • Sale

    Common Stock

    2020-02-19$32.03/sh25,000$800,7501,683,577 total
Transactions
  • Sale

    Common Stock

    2020-02-19$32.03/sh25,000$800,7501,683,577 total
Kong Garheng
10% Owner
Transactions
  • Sale

    Common Stock

    2020-02-19$32.03/sh25,000$800,7501,683,577 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Healthquest Partners, L.P. on December 17, 2019.
  • [F2]The shares are directly held by Sofinnova HealthQuest Partners, L.P. ("HealthQuest"). HealthQuest Venture Management, L.L.C. ("HQVM"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.

Issuer

CASTLE BIOSCIENCES INC

CIK 0001447362

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001579382

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:22 PM ET
Size
8.7 KB